Skip to content
Search

Latest Stories

Submit Guest Post

Global Covid-19 cases surge amid emergence of JN.1 variant

The latest spike has prompted health authorities in multiple countries

JN.1 Variant Drives Global Spike in Covid-19 Cases

India has also recorded a slight uptick in Covid-19 cases

iStock

Covid-19 cases are rising once again across several parts of the world, driven by the spread of the JN.1 variant – a new sub-lineage of Omicron known for its high transmissibility. While symptoms remain mostly mild, the latest spike has prompted health authorities in multiple countries to issue fresh public health advisories.

Cases are rising across Asia

Singapore has seen a sharp increase in cases, with 14,200 infections reported in the week ending 3 May, up from 11,100 the previous week. Hospital admissions also rose to an average of 133 per day, though the number of patients requiring intensive care fell slightly from three to two daily.


Hong Kong’s Centre for Health Protection described current virus activity as “quite high”, with the city recording its highest rate of respiratory samples testing positive in over a year. Authorities are monitoring the situation closely.

In Thailand, the latest surge is mostly affecting people aged 30 to 39, with health experts warning of more cases in the coming weeks. China, too, is experiencing a resurgence, although official figures remain limited.

India reports a modest increase

India has also recorded a slight uptick in Covid-19 cases. As of 19 May, the country had 257 active infections, with Kerala reporting the highest number (69), followed by Maharashtra (44) and Tamil Nadu (34). According to experts, most cases remain mild and do not require hospitalisation.

Health officials say the rise is partly due to the spread of the JN.1 variant, a drop in population-level immunity, and seasonal factors affecting people’s health. The increase in international travel is also believed to be contributing to the current wave.

What is the JN.1 variant?

The JN.1 variant has been labelled a “variant of interest” by global health bodies because of how quickly it spreads. Its symptoms include fever, sore throat, fatigue and mild respiratory issues. However, the severity of illness appears to remain low, particularly among those who have been vaccinated.

The variant has not been linked to increased hospital admissions or deaths, but public health authorities continue to urge caution.

Global health response

Authorities in affected countries are encouraging people to wear masks in crowded spaces, practise good hand hygiene, and stay home if they experience symptoms. While lockdowns and strict restrictions are not currently being considered, local measures could be introduced if hospital pressures increase.

In response to the broader pandemic preparedness challenge, the World Health Organisation recently adopted a historic Pandemic Agreement. The new framework aims to improve global cooperation and ensure a more equitable response to future pandemics, particularly in low- and middle-income countries.

As the world continues to navigate waves of Covid-19, experts are reminding the public not to become complacent. With new variants likely to emerge, maintaining basic precautions remains crucial in preventing further spread.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cancer treatment

The NHS availability announced in September 2026 applies to eligible patients in England. The treatment has already been available in Scotland for more than two years.

What is Enhertu and how could the new NHS breast cancer treatment help patients?

Highlights:
  • Enhertu is a targeted treatment for certain HER2-low breast cancers.
  • It is available for around 1,000 women in England.
  • The drug can extend survival compared with chemotherapy.
  • NICE initially rejected widespread NHS use in 2024.
  • The decision was reversed after a commercial agreement was reached.

Breast cancer treatment continues to evolve as researchers develop therapies aimed at specific characteristics of cancer cells. One such treatment is Enhertu, which has now become available on the NHS in England for people with a particular type of advanced breast cancer.

The treatment is intended for patients with HER2-low breast cancer that cannot be removed through surgery or has spread to other parts of the body. This is known as metastatic breast cancer. According to the latest announcement, around 1,000 women in England will be eligible for the treatment.

Keep ReadingShow less